OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms
Despoina Pantazi, Alexandros D. Tselepis
Thrombosis Research (2022) Vol. 213, pp. S95-S102
Closed Access | Times Cited: 23
Despoina Pantazi, Alexandros D. Tselepis
Thrombosis Research (2022) Vol. 213, pp. S95-S102
Closed Access | Times Cited: 23
Showing 23 citing articles:
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 100
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 100
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events
Íñigo Les, Mireia Martínez, Inés Pérez-Francisco, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1629-1629
Open Access | Times Cited: 45
Íñigo Les, Mireia Martínez, Inés Pérez-Francisco, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1629-1629
Open Access | Times Cited: 45
A theoretical approach on the possibility of using α-phographene, g-X3N4 nanosheets, and C19X fullerenes for adsorption and drug delivery of a proteasome inhibitor drug
Seyyed Amir Siadati, Mohammad Ali Ebrahimzadeh, Rezvan Yazdian–Robati, et al.
Diamond and Related Materials (2024) Vol. 147, pp. 111344-111344
Closed Access | Times Cited: 6
Seyyed Amir Siadati, Mohammad Ali Ebrahimzadeh, Rezvan Yazdian–Robati, et al.
Diamond and Related Materials (2024) Vol. 147, pp. 111344-111344
Closed Access | Times Cited: 6
Oxidized phospholipids and lipoprotein‐associated phospholipase A2 (Lp‐PLA2 ) in atherosclerotic cardiovascular disease: An update
Despoina Pantazi, Constantinos C. Tellis, Alexandros D. Tselepis
BioFactors (2022) Vol. 48, Iss. 6, pp. 1257-1270
Closed Access | Times Cited: 28
Despoina Pantazi, Constantinos C. Tellis, Alexandros D. Tselepis
BioFactors (2022) Vol. 48, Iss. 6, pp. 1257-1270
Closed Access | Times Cited: 28
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions
Chunping Liu, Huiqi Chen, Sien Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115373-115373
Open Access | Times Cited: 14
Chunping Liu, Huiqi Chen, Sien Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115373-115373
Open Access | Times Cited: 14
Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond
Xin Li, Yongping Lin, Lin Song, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Xin Li, Yongping Lin, Lin Song, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Cardiotoxicity of Anticancer Drugs
И. В. Майбородин, A. O. Shumeikina, В. И. Майбородина, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2025) Vol. 69, Iss. 9-10, pp. 91-107
Open Access
И. В. Майбородин, A. O. Shumeikina, В. И. Майбородина, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2025) Vol. 69, Iss. 9-10, pp. 91-107
Open Access
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy
Luca Fazzini, N Campana, Stefano Cossu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1286-1286
Open Access
Luca Fazzini, N Campana, Stefano Cossu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1286-1286
Open Access
A theoretical approach to the possibility of applying the C19Al, C19B, C19N, C19Si, and C20 fullerene as well as the g-B3N4, g-C3N4, and g-Si3P4 nanosheets as carriers for drug delivery (and sensors for detection of the residue) of the Janus kinase inhibitor tofacitinib
Seyyed Amir Siadati, Mohammad Ali Ebrahimzadeh, Esmaeil Babanezhad, et al.
Chemistry of Heterocyclic Compounds (2025)
Closed Access
Seyyed Amir Siadati, Mohammad Ali Ebrahimzadeh, Esmaeil Babanezhad, et al.
Chemistry of Heterocyclic Compounds (2025)
Closed Access
From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies
Valerio Nardone, Dafne Ruggiero, Maria Giovanna Chini, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1059-1059
Open Access
Valerio Nardone, Dafne Ruggiero, Maria Giovanna Chini, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1059-1059
Open Access
Anlotinib-associated pulmonary embolism in brainstem glioblastoma treatment: a case report
Jun Zhao, Yongli Zhang, Ke-Jun Qu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jun Zhao, Yongli Zhang, Ke-Jun Qu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo‐Moya, et al.
Redox Report (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo‐Moya, et al.
Redox Report (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Ketao Li, Wan Chen, Liping Ma, et al.
Environmental Research (2023) Vol. 244, pp. 117264-117264
Closed Access | Times Cited: 7
Ketao Li, Wan Chen, Liping Ma, et al.
Environmental Research (2023) Vol. 244, pp. 117264-117264
Closed Access | Times Cited: 7
Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs—Anthracyclines
Yuanyuan Chen, Wenwen Yang, Xiaoshan Cui, et al.
Biology (2024) Vol. 13, Iss. 9, pp. 689-689
Open Access | Times Cited: 2
Yuanyuan Chen, Wenwen Yang, Xiaoshan Cui, et al.
Biology (2024) Vol. 13, Iss. 9, pp. 689-689
Open Access | Times Cited: 2
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies
Despoina Pantazi, Dimitrios Alivertis, Alexandros D. Tselepis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 897-913
Closed Access | Times Cited: 1
Despoina Pantazi, Dimitrios Alivertis, Alexandros D. Tselepis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 897-913
Closed Access | Times Cited: 1
A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer
Alice Bernasconi, Zanga Alessio, Peter Lucas, et al.
(2024)
Closed Access
Alice Bernasconi, Zanga Alessio, Peter Lucas, et al.
(2024)
Closed Access
Oxidative Stress Adverse Effects in Histological Changes Induced by Anticancer Drugs: A Review Article
Dalia Amer khudhair, Zainab Hayder Jaber Alkufaishi, Teeb M. Jaafar Al-khafaji
Journal of Medical and Health Studies (2024) Vol. 5, Iss. 2, pp. 125-132
Open Access
Dalia Amer khudhair, Zainab Hayder Jaber Alkufaishi, Teeb M. Jaafar Al-khafaji
Journal of Medical and Health Studies (2024) Vol. 5, Iss. 2, pp. 125-132
Open Access
From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer
Alice Bernasconi, Alessio Zanga, Peter Lucas, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3643-3643
Open Access
Alice Bernasconi, Alessio Zanga, Peter Lucas, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3643-3643
Open Access
Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular events
Hajime Matsuo, Hiroyuki Tanaka, Kiri Endo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-5
Closed Access
Hajime Matsuo, Hiroyuki Tanaka, Kiri Endo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-5
Closed Access
Cardio-Oncology for the Primary Care Provider
Nikita Jhawar, Alyssa McPherson, Răzvan M. Chirilă, et al.
Romanian Journal of Internal Medicine (2023) Vol. 61, Iss. 3, pp. 127-134
Open Access | Times Cited: 1
Nikita Jhawar, Alyssa McPherson, Răzvan M. Chirilă, et al.
Romanian Journal of Internal Medicine (2023) Vol. 61, Iss. 3, pp. 127-134
Open Access | Times Cited: 1
Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study
Lizhi Cao, Xiaoying Wang, Yuzhong Yan, et al.
Medicine (2023) Vol. 102, Iss. 51, pp. e36705-e36705
Open Access | Times Cited: 1
Lizhi Cao, Xiaoying Wang, Yuzhong Yan, et al.
Medicine (2023) Vol. 102, Iss. 51, pp. e36705-e36705
Open Access | Times Cited: 1
Advances in Chemotherapy-Related Cardiotoxicity
·阿吉艾科拜尔 艾吾再力
Advances in Clinical Medicine (2023) Vol. 13, Iss. 11, pp. 17815-17821
Closed Access
·阿吉艾科拜尔 艾吾再力
Advances in Clinical Medicine (2023) Vol. 13, Iss. 11, pp. 17815-17821
Closed Access
